Evaluation of the Efficacy of Treatment of Kawasaki Disease before Day 5 of Illness

Pediatric Cardiology

Volumn 25, Issue 1, 2004, Pages 31-34

  Fong, N C ^a   Hui, Y W ^a   Li, C K ^a   Chiu, M C ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

Early treatment; Efficacy; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DRUG EFFICACY; DRUG MEGADOSE; EARLY TREATMENT; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERSISTENT FEVER; RECRUDESCENT FEVER; RETREATMENT; THERAPY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 0942297988     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-003-0558-4     Document Type: Article

References (12)

1. Burns JC, Capparelli EV, Brown JA, et al. (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 14:1144-1148
2. Falcini F, Ermini M, Trapani S, et al. (1994) Efficacy and safety of immunoglobulin retreatment in Kawasaki disease. J Pediatr 125:672-673
3. Han RK, Silverman ED, Newman A, McCrindle BW (2000) Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 154:694-699
4. Ichida I, Fatica NS, Eagle MA, et al. (1987) Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Pediatrics 80:828-835
5. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy 16:178-222
6. Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388-392
7. Newburger JW, Takahashi M, Beiser AS, et al. (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
8. Newburger JW, Takahashi M, Burns JC, et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
9. Sundel RP, Burns TC, Baker A, Beiser A (1993) Gamma globulin retreatment in Kawasaki disease. J Pediatr 123:657-659
10. Tse SML, Silverman ED, McCrindle BW, Yeung RSM (2002) Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 140:450-455
11. Wright WA, Newburger JW, Baker A, Sundel RP (1996) Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroid. J Pediatr 128:146-149
12. Yanagawa H, Nakamura Y, Sakata K, Yashiro M (1997) Use of intravenous gamma globulin for Kawasaki disease: effects on cardiac sequelae. Pediatr Cardiol 18:19-23